X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (903) 903
Publication (170) 170
Conference Proceeding (45) 45
Book Review (42) 42
Book Chapter (16) 16
Patent (8) 8
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (459) 459
humans (422) 422
oncology (364) 364
female (202) 202
lung neoplasms - pathology (193) 193
male (180) 180
lung cancer (175) 175
lung neoplasms - genetics (172) 172
article (162) 162
cancer (152) 152
middle aged (140) 140
aged (127) 127
expression (108) 108
mutation (108) 108
lung neoplasms - metabolism (103) 103
cell line, tumor (102) 102
carcinoma, non-small-cell lung - genetics (95) 95
adult (94) 94
carcinoma, non-small-cell lung - pathology (94) 94
animals (91) 91
immunohistochemistry (91) 91
prognosis (90) 90
tumors (87) 87
adenocarcinoma (84) 84
gene expression regulation, neoplastic (80) 80
mice (80) 80
adenocarcinoma - pathology (75) 75
cell biology (75) 75
pathology (74) 74
respiratory system (73) 73
adenocarcinoma - genetics (72) 72
carcinoma (71) 71
lung neoplasms - drug therapy (70) 70
aged, 80 and over (68) 68
carcinoma, non-small-cell lung - metabolism (58) 58
mutations (57) 57
survival (57) 57
gene expression (54) 54
genetic aspects (51) 51
neoplasm staging (51) 51
lung neoplasms - mortality (50) 50
breast-cancer (48) 48
lung (47) 47
respiratory tract diseases (47) 47
carcinoma, non-small-cell lung - drug therapy (46) 46
research (45) 45
adenocarcinoma - metabolism (42) 42
gene (42) 42
carcinoma, squamous cell - genetics (39) 39
loss of heterozygosity (39) 39
abridged index medicus (38) 38
analysis (38) 38
carcinoma, non-small-cell lung - mortality (37) 37
disease-free survival (37) 37
activation (36) 36
carcinoma, squamous cell - pathology (36) 36
polymerase chain reaction (36) 36
signal transduction (35) 35
identification (34) 34
apoptosis (33) 33
biochemistry & molecular biology (33) 33
biology (33) 33
chemotherapy (33) 33
biomarkers, tumor - genetics (32) 32
genes (32) 32
kaplan-meier estimate (32) 32
metastasis (32) 32
proteins (32) 32
care and treatment (31) 31
gefitinib (31) 31
gene expression profiling (31) 31
cell proliferation (30) 30
dna methylation (30) 30
gene-expression (30) 30
lung-cancer (30) 30
multidisciplinary sciences (30) 30
pathogenesis (30) 30
therapy (30) 30
egfr (29) 29
health aspects (29) 29
neoplasms - genetics (29) 29
non-small cell lung cancer (29) 29
receptor, epidermal growth factor - genetics (29) 29
treatment outcome (29) 29
adenocarcinoma of lung (28) 28
biomarkers (28) 28
cell lung-cancer (28) 28
growth-factor receptor (28) 28
lung cancer, non-small cell (28) 28
cells (27) 27
nsclc (27) 27
tumor cells, cultured (27) 27
adenocarcinoma - mortality (25) 25
biomarkers, tumor - analysis (25) 25
survival analysis (25) 25
biomarkers, tumor - metabolism (24) 24
carcinoma, squamous cell - metabolism (24) 24
genomics (24) 24
hematology, oncology and palliative medicine (24) 24
immunotherapy (24) 24
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S116 - S118
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S172 - S172
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2016, Volume 113, Issue 11, pp. E1555 - E1564
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2014, Volume 111, Issue 41, pp. 14788 - 14793
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 05/2014, Volume 311, Issue 19, pp. 1998 - 2006
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2014, Volume 20, Issue 2 Supplement, pp. IA11 - IA11
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 4, pp. e34833 - e34833
Background: Tumor suppressor gene TUSC2/FUS1 (TUSC2) is frequently inactivated early in lung cancer development. TUSC2 mediates apoptosis in cancer cells but... 
FUS1 PROTEIN | DNA COMPLEXES | LIPOSOME | ADENOVIRUS VECTOR | HOMOZYGOUS DELETION REGION | TUMOR-SUPPRESSOR GENES | BIOLOGY | LUNG-CANCER CELLS | HUMAN-CHROMOSOME 3P21.3 | EXPRESSION | P53 | Lung Neoplasms - genetics | Gene Transfer Techniques | Lung Neoplasms - drug therapy | Tumor Suppressor Proteins - metabolism | Tumor Suppressor Proteins - administration & dosage | Tumor Suppressor Proteins - therapeutic use | Apoptosis - drug effects | Fatty Acids, Monounsaturated - administration & dosage | Humans | Apoptosis - genetics | Gene Expression Profiling | Positron-Emission Tomography | Reverse Transcriptase Polymerase Chain Reaction | Dose-Response Relationship, Drug | Maximum Tolerated Dose | Nanoparticles - therapeutic use | Quaternary Ammonium Compounds - administration & dosage | Nanoparticles - administration & dosage | Plasmids - administration & dosage | Genetic Therapy - methods | Medical colleges | PET imaging | Lung cancer | Genes | Clinical trials | Metastasis | Gene expression | Nanoparticles | Cytokinins | Chemotherapy | Messenger RNA | Gene therapy | Cancer | Apoptosis | Intravenous administration | Emission analysis | Correlation coefficients | Lung | Medical services | Staining | Lipids | Dosage | Tissues | Cancer therapies | Metabolic response | Anticancer properties | Metastases | Genetic abnormalities | Platinum | Protein folding | Chlorides | Peripheral blood | Trimethylammonium chloride | Tomography | Pretreatment | Deoxyribonucleic acid--DNA | Correlation coefficient | Enzymes | Abnormalities | Positron emission | Patients | Vectors (Biology) | Cholesterol | Polymerase chain reaction | Biopsy | Adenoviruses | Quality control | Tumor suppressor genes | Mutation | Positron emission tomography | Tumors | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Nature Communications, ISSN 2041-1723, 10/2014, Volume 5, Issue 1, pp. 5241 - 5241
Journal Article
Nature, ISSN 0028-0836, 10/2010, Volume 467, Issue 7318, pp. 986 - 990
Aberrant expression of microRNAs (miRNAs) and the enzymes that control their processing have been reported in multiple biological processes including primary... 
MUTANT | LI-FRAUMENI-SYNDROME | MULTIDISCIPLINARY SCIENCES | P63 EXPRESSION | MICE | CANCER | P73 | CARCINOMA | PROGRESSION | P53 | FAMILY | Genomic Instability | Endoribonucleases - genetics | Humans | Transcriptional Activation | Gene Expression Regulation, Neoplastic | Male | MicroRNAs - metabolism | Phosphoproteins - metabolism | Promoter Regions, Genetic - genetics | DEAD-box RNA Helicases - biosynthesis | Neoplasms - genetics | Cellular Senescence | Tumor Suppressor Proteins - deficiency | DEAD-box RNA Helicases - deficiency | Genes, Tumor Suppressor - physiology | Tumor Suppressor Proteins - genetics | Trans-Activators - genetics | Female | DEAD-box RNA Helicases - metabolism | Cell Line | Neoplasms - secretion | Tumor Suppressor Proteins - metabolism | Ribonuclease III - genetics | Ribonuclease III - metabolism | Endoribonucleases - metabolism | Mice, Inbred C57BL | MicroRNAs - biosynthesis | Phosphoproteins - genetics | Ribonuclease III - biosynthesis | Ribonuclease III - deficiency | DEAD-box RNA Helicases - genetics | Neoplasm Metastasis - genetics | Animals | Trans-Activators - deficiency | Phosphoproteins - deficiency | Cell Line, Tumor | Trans-Activators - metabolism | Mice | MicroRNAs - genetics | Transcription Factors | Neoplasms - pathology | Care and treatment | MicroRNA | Tumor suppressor genes | Genetic aspects | Metastasis | Research | Health aspects | Risk factors | Genotype & phenotype | Medical research | Binding sites | Tumors | Index Medicus
Journal Article